Literature DB >> 28393992

GRP78 levels, regional fat distribution and endometrial cáncer.

Răzvan Ciortea1, Andrei M Malutan1, Lenuta M Angheluta1, Carmen E Bucuri1, Maria P Rada1, Dan Mihu1.   

Abstract

BACKGROUND: The association of obesity with endometrial cancer is supported by the presence of endoplasmic reticulum (ER) stress in the adipocyte. Glucose-regulated protein 78 (GRP78) is a marker for ER stress. This protein is a central regulator of ER stress due to its major anti-apoptotic role. It plays an important role in tumor development, progression and chemoresistance. AIM: To look for an association between android and gynoid obesity, plasma GRP78 levels and endometrial cancer.
MATERIAL AND METHODS: Forty four patients with endometrial cancer aged 72 ± 6 years and 44 healthy women aged 55 ± 9 years were studied. Android and gynoid fat distribution were determined by dual X-ray absorptiometry and plasma GRP78 levels were measured.
RESULTS: GRP78 plasma levels were significantly higher in patients with endometrial cancer as compared to the control group. Android fat distribution had a positive correlation with plasma GRP78 levels (p<0.01). Gynoid fat had a negative correlation with plasma GRP78 levels (p<0.01).
CONCLUSIONS: GRP78 levels are associated with the distribution of adipose tissue and are higher in patients with endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28393992     DOI: 10.4067/S0034-98872016001200009

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

1.  The meta and bioinformatics analysis of GRP78 expression in gastric cancer.

Authors:  Hua-Chuan Zheng; Bao-Cheng Gong; Shuang Zhao
Journal:  Oncotarget       Date:  2017-08-18

2.  Co-downregulation of GRP78 and GRP94 Induces Apoptosis and Inhibits Migration in Prostate Cancer Cells.

Authors:  Tong Lu; Yue Wang; Kang Xu; Zhijun Zhou; Juan Gong; Yingang Zhang; Hua Gong; Qiang Dai; Jun Yang; Biao Xiong; Ze Song; Gang Yang
Journal:  Open Life Sci       Date:  2019-07-22       Impact factor: 0.938

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.